Is It Time To Leave Your CDMO?
This segment of the Outsourced Pharma Live event, “Your CDMO Quality Oversight Is Not Working,” examines how sponsors can determine whether a troubled CDMO relationship can be repaired. Andrea and Greg discuss what meaningful ownership of a problem looks like, why repeated resistance to feedback raises concerns about quality culture, and how limited funding and lengthy transfer timelines complicate the decision to leave. The conversation emphasizes clear commitments, evidence of improvement, and a shared responsibility for keeping programs moving toward patients. Featuring Andrea Goddard, CTO, CatalYm GmbH, and Greg Whitehead, EVP/CTO, Editas Medicine.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.